{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:42:10Z","timestamp":1792208530255,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["Grant No. 2025ZD0552300"],"award-info":[{"award-number":["Grant No. 2025ZD0552300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1245\/s10434-026-20468-9","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:55:35Z","timestamp":1787680535000},"page":"10125-10137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Validation of Nomograms for Predicting Overall Survival and Recurrence After Upfront Pancreatic Resection for Ductal Adenocarcinoma: A Single-Institution Analysis of 2958 Patients"],"prefix":"10.1245","volume":"33","author":[{"given":"Guoxiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"20468_CR1","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"20468_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"20468_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e31818166d2","volume":"37","author":"M Adham","year":"2008","unstructured":"Adham M, Jaeck D, Le Borgne J, et al. Long-term survival (5\u201320 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions. Pancreas. 2008;37(4):352\u20137.","journal-title":"Pancreas."},{"issue":"3","key":"20468_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267\u201377.","journal-title":"JAMA."},{"issue":"25","key":"20468_CR5","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379(25):2395\u2013406.","journal-title":"N Engl J Med."},{"issue":"2","key":"20468_CR6","first-page":"99","volume":"9","author":"G Garcea","year":"2008","unstructured":"Garcea G, Dennison AR, Pattenden CJ, et al. Survival following curative resection for pancreatic ductal adenocarcinoma: a systematic review of the literature. JOP. 2008;9(2):99\u2013132.","journal-title":"JOP."},{"issue":"8","key":"20468_CR7","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1245\/s10434-024-15281-1","volume":"31","author":"AA Javed","year":"2024","unstructured":"Javed AA, Mahmud O, Fatimi AS, et al. Predictors for long-term survival after resection of pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2024;31(8):4673\u201387.","journal-title":"Ann Surg Oncol."},{"issue":"10073","key":"20468_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","volume":"389","author":"JP Neoptolemos","year":"2017","unstructured":"Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389(10073):1011\u201324.","journal-title":"Lancet."},{"issue":"2","key":"20468_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.21037\/hbsn-24-37","volume":"13","author":"C Springfeld","year":"2024","unstructured":"Springfeld C, Bailey P, Buchler MW, Neoptolemos JP. ESMO 2023 pancreatic cancer guidelines signal stepwise progress. Hepatobiliary Surg Nutr. 2024;13(2):362\u20135.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"10","key":"20468_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jama.2010.1275","volume":"304","author":"JP Neoptolemos","year":"2010","unstructured":"Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304(10):1073\u201381.","journal-title":"JAMA."},{"issue":"16","key":"20468_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1200\/JCO.19.02274","volume":"38","author":"E Versteijne","year":"2020","unstructured":"Versteijne E, Suker M, Groothuis K, et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial. J Clin Oncol. 2020;38(16):1763\u201373.","journal-title":"J Clin Oncol."},{"issue":"8","key":"20468_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.1137","volume":"151","author":"MHG Katz","year":"2016","unstructured":"Katz MHG, Shi Q, Ahmad SA, et al. Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial A021101. JAMA Surg. 2016;151(8):e161137.","journal-title":"JAMA Surg."},{"issue":"7","key":"20468_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/medicina61071121","volume":"61","author":"V Valle","year":"2025","unstructured":"Valle V, Pakataridis P, Marchese T, Ferrari C, Chelmis F, Sorotou IN, Gianniou MA, Dimova A, Tcholakov O, Ielpo B. Comparative analysis of open, laparoscopic, and robotic pancreaticoduodenectomy: a systematic review of randomized controlled trials. Medicina. 2025;61(7):1121.","journal-title":"Medicina"},{"key":"20468_CR14","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th edn. New York: Springer; 2017.","edition":"8"},{"issue":"3 Suppl 1","key":"20468_CR15","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.surg.2012.05.020","volume":"152","author":"CR Ferrone","year":"2012","unstructured":"Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al. Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery. 2012;152(3 Suppl 1):S43\u20139.","journal-title":"Surgery."},{"issue":"3","key":"20468_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584\u201391.","journal-title":"Surgery."},{"issue":"3","key":"20468_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/jnci\/djae269","volume":"117","author":"F Keane","year":"2025","unstructured":"Keane F, O\u2019Connor C, Moss D, et al. Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort. JNCI J Natl Cancer Inst. 2025;117(3):496\u2013506.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"5","key":"20468_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jso.24723","volume":"116","author":"JD Epstein","year":"2017","unstructured":"Epstein JD, Kozak G, Fong ZV, et al. Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma. J Surg Oncol. 2017;116(5):658\u201364.","journal-title":"J Surg Oncol."},{"issue":"4","key":"20468_CR19","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1245\/s10434-022-12976-1","volume":"30","author":"R Anteby","year":"2023","unstructured":"Anteby R, Blaszkowsky LS, Hong TS, et al. Disparities in receipt of adjuvant therapy after upfront surgical resection for pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2023;30(4):2473\u201381.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"20468_CR20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/SLA.0000000000006283","volume":"280","author":"TJ Schouten","year":"2024","unstructured":"Schouten TJ, Kroon VJ, Besselink MG, et al. Perineural invasion is an important prognostic factor in patients with radically resected (R0) and node-negative (pN0) pancreatic cancer. Ann Surg. 2024;280(1):e1\u20139.","journal-title":"Ann Surg."},{"issue":"6","key":"20468_CR21","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1245\/s10434-016-5715-0","volume":"24","author":"H Mogal","year":"2017","unstructured":"Mogal H, Vermilion SA, Dodson R, Hsu FC, Howerton R, Shen P, Clark CJ. Modified frailty index predicts morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol. 2017;24(6):1714\u201321.","journal-title":"Ann Surg Oncol."},{"issue":"7592","key":"20468_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47\u201352.","journal-title":"Nature."},{"issue":"10","key":"20468_CR23","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1002\/cam4.2959","volume":"9","author":"G Li","year":"2020","unstructured":"Li G, Hu Y, Zhou J, et al. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma. Cancer Med. 2020;9(10):3353\u201370.","journal-title":"Cancer Med."},{"issue":"2","key":"20468_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.hpb.2019.07.008","volume":"22","author":"DK DePeralta","year":"2020","unstructured":"DePeralta DK, Ogami T, Zhou JM, et al. Completion of adjuvant therapy in patients with resected pancreatic cancer. HPB. 2020;22(2):241\u20138.","journal-title":"HPB"},{"issue":"7","key":"20468_CR25","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.3390\/curroncol30070482","volume":"30","author":"JJ Biagi","year":"2023","unstructured":"Biagi JJ, Cosby R, Bahl M, et al. Adjuvant chemotherapy and radiotherapy in resected pancreatic ductal adenocarcinoma: a systematic review and clinical practice guideline. Curr Oncol. 2023;30(7):6575\u201386.","journal-title":"Curr Oncol."},{"issue":"3","key":"20468_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","volume":"9","author":"KJ Labori","year":"2024","unstructured":"Labori KJ, Bratlie SO, Andersson B, et al. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024;9(3):205\u201317.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"2","key":"20468_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","volume":"8","author":"P Ghaneh","year":"2023","unstructured":"Ghaneh P, Palmer D, Cicconi S, et al. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8(2):157\u201368.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"17","key":"20468_CR28","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1200\/JCO-24-01378","volume":"43","author":"L Schwarz","year":"2025","unstructured":"Schwarz L, Bachet JB, Meurisse A, et al. Neoadjuvant FOLF(IRIN)OX chemotherapy for resectable pancreatic adenocarcinoma: a multicenter randomized noncomparative phase II trial (PANACHE01-FRENCH08-PRODIGE48 study). J Clin Oncol. 2025;43(17):1984\u201396.","journal-title":"J Clin Oncol."},{"issue":"2","key":"20468_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11605-013-2347-6","volume":"18","author":"N Dusch","year":"2014","unstructured":"Dusch N, Weiss C, Strobel P, et al. Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas: 40 years of experience. J Gastrointest Surg. 2014;18(2):363\u201372.","journal-title":"J Gastrointest Surg."},{"issue":"1","key":"20468_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/AS9.0000000000000486","volume":"5","author":"KTD Yeung","year":"2024","unstructured":"Yeung KTD, Kumar S, Cunningham D, et al. Surgical outcomes following neoadjuvant treatment for locally advanced and borderline resectable pancreatic ductal adenocarcinoma. Ann Surg Open. 2024;5(1):e486.","journal-title":"Ann Surg Open."},{"issue":"5","key":"20468_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.pan.2015.09.008","volume":"15","author":"I Matsuno","year":"2015","unstructured":"Matsuno I, Uza N, Matsumoto T, et al. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: a multi-institutional retrospective study. Pancreatology. 2015;15(5):674\u201380.","journal-title":"Pancreatology."},{"issue":"10","key":"20468_CR32","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt RA, Marayati R, Flate EL, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168\u201378.","journal-title":"Nat Genet."},{"issue":"2","key":"20468_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/01.sla.0000133125.85489.07","volume":"240","author":"MF Brennan","year":"2004","unstructured":"Brennan MF, Kattan MW, Klimstra D, et al. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293\u20138.","journal-title":"Ann Surg."},{"issue":"30","key":"20468_CR34","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1200\/JCO.2005.01.8101","volume":"23","author":"CR Ferrone","year":"2005","unstructured":"Ferrone CR, Kattan MW, Tomlinson JS, et al. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23(30):7529\u201335.","journal-title":"J Clin Oncol."},{"issue":"4","key":"20468_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/bjs.6548","volume":"96","author":"SM de Castro","year":"2009","unstructured":"de Castro SM, Biere SS, Lagarde SM, et al. Validation of a nomogram for predicting survival after resection for adenocarcinoma of the pancreas. Br J Surg. 2009;96(4):417\u201323.","journal-title":"Br J Surg."},{"issue":"4","key":"20468_CR36","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.surg.2022.05.024","volume":"172","author":"G Qiao","year":"2022","unstructured":"Qiao G, Ilagan CH, Fernandez-Del Castillo C, et al. Development and validation of the Massachusetts General Hospital\/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. Surgery. 2022;172(4):1228\u201335.","journal-title":"Surgery."},{"issue":"8","key":"20468_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/oncolo\/oyae155","volume":"29","author":"GP Botta","year":"2024","unstructured":"Botta GP, Abdelrahim M, Drengler RL, et al. Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. Oncologist. 2024;29(8):859\u201369.","journal-title":"Oncologist."},{"issue":"11","key":"20468_CR38","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.hpb.2021.04.004","volume":"23","author":"S Crippa","year":"2021","unstructured":"Crippa S, Bittoni A, Belfiori G, et al. Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology. HPB. 2021;23(11):1666\u201373.","journal-title":"HPB"},{"issue":"4","key":"20468_CR39","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson EA, Sadanandam A, Olson P, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17(4):500\u20133.","journal-title":"Nat Med."}],"updated-by":[{"DOI":"10.1245\/s10434-026-20596-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20468-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:23:04Z","timestamp":1792207384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20468-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20468"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20468-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Table 1, Figs. 3 and 4, and Table S2 were corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-026-20596-2","URL":"https:\/\/doi.org\/10.1245\/s10434-026-20596-2","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Institutional Review Board of Changhai Hospital. The requirement for informed consent was waived due to the retrospective nature of the analysis, which utilized prospectively collected data. The study is reported in accordance with the STROBE guidelines. All patients provided written informed consent to use their clinical data and samples.","order":2,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication was obtained.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}